Cardlytics Company Insiders

CDLX Stock  USD 1.68  0.05  2.89%   
Slightly above 91 percent of Cardlytics' insiders are activelly selling. The current insiders' sentiment regarding investing in Cardlytics stock implies that a very large number of insiders are panicking. Cardlytics employs about 440 people. The company is managed by 16 executives with a total tenure of roughly 6 years, averaging almost 0.0 years of service per executive, having 27.5 employees per reported executive.
Jared Luskin  President
Senior Vice President for Growth Verticals

Insider Sentiment 9

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-07-02Alexis DesienoDisposed 7324 @ 1.78View
2025-04-22Nicholas Hollmeyer LyntonDisposed 303 @ 1.51View
2025-02-18Amit GuptaDisposed 46857 @ 3.4View
2025-01-30Nicholas Hollmeyer LyntonDisposed 3377 @ 3.19View
2025-01-24Amit GuptaDisposed 15160 @ 3.92View
2025-01-03Alexis DesienoDisposed 8854 @ 3.67View
2024-11-15Alexis DesienoDisposed 25118 @ 3.43View
2024-10-24Amit GuptaDisposed 22607 @ 3.85View
2024-10-02Nicholas Hollmeyer LyntonDisposed 5936 @ 3.08View
2024-08-12Scott A HillAcquired 40000 @ 3.58View
2024-07-24Amit GuptaDisposed 22699 @ 8.66View
Monitoring Cardlytics' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Cardlytics Management Team Effectiveness

The company has return on total asset (ROA) of (0.0878) % which means that it has lost $0.0878 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3548) %, meaning that it created substantial loss on money invested by shareholders. Cardlytics' management efficiency ratios could be used to measure how well Cardlytics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.9 in 2025. Return On Capital Employed is likely to drop to -0.84 in 2025. At this time, Cardlytics' Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 190.9 M in 2025, whereas Other Assets are likely to drop slightly above 2.2 M in 2025.
Common Stock Shares Outstanding is likely to drop to about 29.5 M in 2025. Net Loss is likely to rise to about (397.8 M) in 2025

Cardlytics Workforce Comparison

Cardlytics is rated below average in number of employees category among its peers. The total workforce of Communication Services industry is currently estimated at about 28,907. Cardlytics claims roughly 440 in number of employees contributing just under 2% to stocks in Communication Services industry.

Cardlytics Profit Margins

The company has Profit Margin (PM) of (0.65) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.31.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.30.4344
Way Down
Slightly volatile

Cardlytics Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cardlytics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cardlytics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Cardlytics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Cardlytics Notable Stakeholders

A Cardlytics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cardlytics often face trade-offs trying to please all of them. Cardlytics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cardlytics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Amit GuptaCEO DirectorProfile
Jared LuskinSenior Vice President for Growth VerticalsProfile
Evelyne ForesterChief OfficerProfile
Carson NappsChief OfficerProfile
Jose SingerChief OfficerProfile
Alexis DeSienoChief OfficerProfile
Karim TemsamaniCEO DirectorProfile
James HartVP PeopleProfile
Kirk EsqSecProfile
Peter DaviesHead OperationsProfile
Nick LyntonChief SecretaryProfile
Craig SnodgrassChief OfficerProfile
Peter ChanChief OfficerProfile
Angie AmbergHead CommunicationsProfile
Andrew ChristiansenChief OfficerProfile
Rory MitchellChief OfficerProfile

About Cardlytics Management Performance

The success or failure of an entity such as Cardlytics often depends on how effective the management is. Cardlytics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cardlytics management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cardlytics management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.85)(0.90)
Return On Capital Employed(0.80)(0.84)
Return On Assets(0.48)(0.51)
Return On Equity(2.70)(2.57)
Please note, the imprecision that can be found in Cardlytics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cardlytics. Check Cardlytics' Beneish M Score to see the likelihood of Cardlytics' management manipulating its earnings.

Cardlytics Workforce Analysis

Traditionally, organizations such as Cardlytics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cardlytics within its industry.

Cardlytics Manpower Efficiency

Return on Cardlytics Manpower

Revenue Per Employee632.5K
Revenue Per Executive17.4M
Net Loss Per Employee430.2K
Net Loss Per Executive11.8M
Working Capital Per Employee66K
Working Capital Per Executive1.8M

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.